PathAI is a leading company in AI-powered pathology, dedicated to improving patient outcomes by accelerating drug development and enhancing diagnostic accuracy. They partner with biopharmaceutical companies, diagnostic companies, contract research organizations (CROs), and academic medical centers. Their core offering is a sophisticated platform that integrates high-resolution whole slide imaging with advanced AI algorithms. This technology provides quantitative insights into disease pathology, supporting critical applications in research, therapy development, and diagnostic workflows. Their solutions aim to streamline biomarker discovery, validate therapeutic targets, and improve the precision and efficiency of pathological assessments.
Quick Info